Request Demo
Last update 31 Aug 2026
Anti-CD70｜PSMA CAR-T (Shenzhen Geno-Immune Medical )
Last update 31 Aug 2026
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms- |
Target |
Action inhibitors |
Mechanism CD70 inhibitors(CD70 antigen inhibitors), PSMA inhibitors(Prostate-specific membrane antigen inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Anti-CD70｜PSMA CAR-T (Shenzhen Geno-Immune Medical )NCT05437341
PSMA/CD70 Bi-specific CAR-T Cells for Cancer Treatment
100 Clinical Results associated with Anti-CD70｜PSMA CAR-T (Shenzhen Geno-Immune Medical )
Login to view more data
100 Translational Medicine associated with Anti-CD70｜PSMA CAR-T (Shenzhen Geno-Immune Medical )
Login to view more data
100 Patents (Medical) associated with Anti-CD70｜PSMA CAR-T (Shenzhen Geno-Immune Medical )
Login to view more data
100 Deals associated with Anti-CD70｜PSMA CAR-T (Shenzhen Geno-Immune Medical )
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Brain Cancer | Phase 2 | China | 01 Jun 2026 | |
| CD70 positive Neoplasms | Phase 2 | China | 01 Jun 2026 | |
| Glioma | Phase 2 | China | 01 Jun 2026 | |
| Lymphoma | Phase 2 | China | 01 Jun 2026 | |
| Melanoma | Phase 2 | China | 01 Jun 2026 | |
| Neuroblastoma | Phase 2 | China | 01 Jun 2026 | |
| Prostatic Cancer | Phase 2 | China | 01 Jun 2026 | |
| PSMA-Positive Tumor | Phase 2 | China | 01 Jun 2026 | |
| Refractory Cancer | Phase 2 | China | 01 Jun 2026 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free